The risk of narrow protection
A growing number of biotechnology inventions relate to peptides, oligonucleotides and other small molecules that could be used in therapeutic applications. Caroline Pallard explains the challenges of patenting such inventions.
Stricter examination requirements in Canada
Two pharmaceutical cases highlight recent developments in Canadian patent law relating to duty of candour during patent prosecution and patent claim construction, says Katie Wang.
Product definition in Swedish SPCs
There is a contradiction at the heart of product definition in Swedish supplementary protection certificates, says Hampus Rystedt.